Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 24: The MATTERHORN Trial
Author(s): Stephan Baldus Added: 1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more

Intervention
Left Atrium Role in Secondary Mitral Regurgitation
Author(s): Markos Koukos , Yannis Dimitroglou , Dimitrios Tsartsalis , et al Added: 2 years ago

Vascular Disease and Surgery

Imaging & Diagnostics
TCT 24: The CLASP IID 2-Year RCT and Registry Outcomes
Author(s): Firas Zahr Added: 1 year ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP… View more

Intervention
30th Annual Meeting of the ISCP
Author(s): Paula Bouzón Iglesias , Alejandro Gullón de la Roza , Laura Pérez Bacigalupe , et al Added: 1 month ago

Intervention

Prevention & Chronic Conditions
Simon Cheung-Chi Lam
Job title: Interventional Cardiologist
Dr Simon Cheung-Chi Lam graduated from the Faculty of Medicine, University of Hong Kong in 2003. He is an interventional cardiologist from the Division of Cardiology, Department of Medicine, Queen Mary Hospital, Hong Kong. He received his post-fellowship training in Structural and Congenital Heart Intervention in Cardiovascular Center Frankfurt, Germany under Prof Horst Sievert in 2012-2013.His… View more
Semaglutide May Aid Vascular Repair in High-Risk Patients
Added: 2 months ago Source:  Radcliffe CVRM
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are known to reduce major atherosclerotic cardiovascular events, but the full extent of their mechanisms is still being explored. The SEMA-VR CardioLink-15 trial investigated whether semaglutide affects the levels of circulating vascular regenerative (VR) cells, which are involved in vessel repair and may modulate atherothrombotic risk.¹… View more

Cardiovascular Kidney Metabolic
EuroPCR 25: The FATE Registry
Author(s): Fedrico de Marco Added: 1 year ago
EuroPCR 2025 - Outcomes from the FATE Registry show coapttion gaps are at the upper limit of treatability in this patient group using current tTEER devices.Dr Fedrico de Marco (Centro Cardiologico Monzino IRCCS, Milan, IT) joins us to discuss the management and outcomes from the FATE registry, which investigated 123 case of failed tricuspid transcatheter edge-to-edge repair (tTEER) with all… View more

Intervention
Atrioventricular (AV) Valves Summit 2024
Author(s): Marco Metra , Victoria Delgado , Nicole Karam , et al Added: 1 year ago
In this series of short interviews filmed at AV Valves Summit 2024, leading experts offer valuable insights and professional opinions on transcatheter mitral and tricuspid interventions.The sessions explore a wide array of topics, including advancements in TEER techniques, the evolving focus on patient quality of life, the ongoing debate between repair versus replacement, and the most effective… View more

Vascular Disease and Surgery
MicroRNAs for Cardiac Regeneration
Author(s): Camilla Olianti , Mauro Giacca Added: 8 months ago

Prevention & Chronic Conditions

Heart Failure
Same-day Discharge Following PCI: A Meta-analysis of RCTs
Author(s): Ngoc Huy Nguyen , Thanh Ngoc Le , Hoai Thi Thu Nguyen , et al Added: 11 months ago

Intervention